Cell Therapy That Repairs Cornea Damage with Patient鈥檚 Own Stem Cells Achieves Positive Phase I Trial Results
Massachusetts Eye and EarCultivated autologous limbal epithelial cells (CALEC) transplant, in which stem cells from the healthy eye and transplanted into the injured eye, for significant cornea injuries was found safe and led to gains in preliminary phase I clinical trial.